CDCP1 and prostate cancer: While the ATF has previously been shown to be shed from the surface of prostate cancer cells in vitro15,16 and to be present in the serum of colorectal cancer patients 17, this study for the first time demonstrated that this fragment of CDCP1 could be retained on the cell surface.